MedCity News November 11, 2024
Matt Manning

Top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and enhance performance for optimal outcomes.

Specialty medications are estimated to comprise 65% of drug spending by 2025, and health systems are rapidly addressing new industry demands with in-house programs to support high-cost, high-touch drug dispensing.

While entity-owned specialty pharmacies meet a clear need for patients requiring complex therapies, getting these programs up and running is only part of the battle. Without strategic optimization across integrated channels, a specialty pharmacy’s long-term success hangs in the balance, but determining how to approach this endeavor often leaves health systems stumped.

Let’s explore the top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Healthcare supply chain, pharmacy costs to rise in 2025: report
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
Behind Intermountain Health's in-house PBM

Share This Article